Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
The British Journal of Dermatology|October 7, 2014
Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laserL Gao, D M Nadora, S Phan, et al.
Cancer|December 25, 1992
A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02W J Curran, C B Scott, J S Nelson, et al.
Neurology|March 23, 2005
Consumption of milk and calcium in midlife and the future risk of Parkinson diseaseM Park, G W Ross, H Petrovitch, et al.
Journal of the National Cancer Institute|May 5, 1993
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trialsW J Curran, C B Scott, J Horton, et al.
Journal of Neuro-Oncology|March 11, 1992
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsW J Curran, C B Scott, J Horton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02W J Curran, C B Scott, A S Weinstein, et al.
Lasers in Surgery and Medicine|January 1, 1997
Ablation of human nail by pulsed lasersJ Neev, J S Nelson, M Critelli, et al.
Neurology|October 9, 2002
Midlife adiposity and the future risk of Parkinson's diseaseR D Abbott, G W Ross, L R White, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1988
Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology GroupG E Laramore, M Diener-West, T W Griffin, et al.
Archives of Dermatology|June 1, 1997
Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging studyE W Jeffes, J L McCullough, G D Weinstein, et al.
Pageof 21